Clomiphene Citrate 50mg/tab 50 Tablets by Hilma Biocare

Usage

1. Confirm all suppressive AAS compounds have cleared plasma (at minimum three half-lives of the longest-acting ester) before the first Clomiphene tablet — initiating too early wastes tablets against ongoing exogenous androgen suppression.
2. If HCG pre-loading is indicated (cycles over 16 weeks, stacked compounds, 19-nor androgens), complete the 10–14 day HCG phase and allow 24–48 hours clearance before opening the Clomiphene pack.
3. Begin Phase 1 at 100 mg daily (two 50 mg tablets taken together or split morning/evening) for the first fourteen days — consistency of timing reduces plasma-level fluctuation.
4. Step down to one tablet (50 mg) daily from day 15 through day 28; do not skip the week-four bloodwork — serum LH, FSH, and total testosterone results determine whether to exit at week four or continue into the taper phase.
5. If bloodwork at week four supports continuation, split one tablet and take 25 mg daily through weeks five and six; the HPLC-confirmed compression uniformity of Hilma Biocare tablets makes this split clinically reliable.
6. Repeat bloodwork at weeks eight and twelve post-Clomiphene to verify sustained autonomous testosterone production; document all values to establish a recovery baseline for future cycle planning.

Warnings

Frequently asked questions

What makes PCT after a heavy anabolic cycle fundamentally different from a standard post-cycle protocol?

Heavy-cycle PCT must contend with prolonged Leydig cell dormancy and near-zero gonadotropin output lasting weeks or months, not days. The pituitary's response to Clomiphene is slower and weaker under these conditions, necessitating a higher opening dose (typically 100 mg daily), a longer overall protocol duration of five to six weeks, and mandatory bloodwork to confirm axis reassertion before discontinuing the SERM.

When should HCG be used before starting Clomiphene Citrate after a long or stacked cycle?

HCG pre-loading is advisable whenever cycles exceed sixteen weeks, involve multiple suppressive compounds, or include 19-nor androgens, which are known to create deeper and more persistent Leydig cell desensitisation. A typical pre-phase runs 500–1000 IU every other day for ten to fourteen days before Clomiphene begins, restoring Leydig cell responsiveness so the subsequent gonadotropin surge from Clomiphene has a functional target.

How long does full HPTA recovery realistically take after a prolonged heavy steroid cycle?

Clinical evidence suggests complete endogenous testosterone normalisation after a heavy cycle can take three to six months, with the initial SERM-assisted phase covering the first four to six weeks. Serum LH, FSH, and total testosterone measured at the four-week mark determine whether the Clomiphene protocol needs extension. Some individuals require a repeat bloodwork assessment at twelve weeks before discontinuing all supportive therapy.

Can the 50mg Hilma Biocare tablet be split accurately for the taper phase of a heavy-cycle PCT protocol?

Yes. Hilma Biocare's GMP-certified tablet compression process is validated by HPLC for uniformity across the tablet matrix, meaning a scored or clean-cut split yields a dose proportional to 25 mg with analytical confidence. This is relevant during weeks five and six of a six-week heavy-cycle protocol when the taper drops to 25 mg daily — a phase that would otherwise require a separately sourced lower-dose product.

Why is 50mg per tablet the most practical concentration for heavy-cycle PCT with Clomiphene Citrate?

A 50 mg tablet is the highest per-unit concentration in the standard clomiphene oral range and eliminates multi-tablet stacking during the 100 mg loading phase — just two tablets rather than four or more lower-dose units. This simplifies compliance during the most demanding phase of recovery, reduces pill burden, and means the 50-tablet pack delivers sufficient total dose to cover a complete six-week tapered heavy-cycle protocol without requiring a second purchase. (2) angle_used

Manufacturer

The presentation architecture for Hilma Biocare's oral tablet line is built around discrete batch documentation: the 50-tablet Clomiphene Citrate 50mg/tab pack carries a batch record that is exclusive to its production run, covering API identity and potency data captured by HPLC at the raw-material intake stage, in-process tablet-weight figures recorded under GMP-certified compression parameters, and a finished-product HPLC re-verification step that anchors the per-tablet content claim to an instrument-generated data point rather than a theoretical fill calculation. The tablets are sealed in a format designed to preserve physical integrity and moisture stability across the distribution chain — a presentation consideration that is particularly relevant for an oral SERM where tablet uniformity directly affects dose accuracy during the split-tablet taper phase of a heavy-cycle protocol. Each pack is traceable to its batch record through Hilma Biocare's lot-coding infrastructure, allowing the authenticity and release status of any unit to be verified against the company's documentation system.